Shenzhen Capital Group

Accro Bioscience is a biopharmaceutical company that specializes in the development of innovative small molecule drugs aimed at treating inflammatory and autoimmune diseases, as well as cancer. The company conducts research on the molecular mechanisms underlying regulated cell death processes, including necroptosis, pyroptosis, and ferroptosis. By understanding these mechanisms, Accro Bioscience aims to enhance current therapeutic approaches and address specific pathologies associated with various human diseases.

Transcend Vivoscope is a biotechnology company that focuses on the development of advanced microscopy imaging products and solutions. Its high-resolution imaging systems are designed to meet the needs of healthcare providers, enabling them to create innovative tools for various applications, including 3D cell biology, neuroscience, developmental biology, and clinical medicine. By offering cutting-edge technology, Transcend Vivoscope aims to enhance the capabilities of healthcare professionals in their research and clinical practices.

Nuoyimeier is a developer of implantable consumables.

Maxvax Health is a biotechnology company focused on the development and commercialization of innovative vaccines. The company specializes in vaccine technology targeting viral diseases, including rotavirus, shingles, and herpes. By advancing these vaccines, Maxvax Health aims to enhance treatment options for healthcare professionals and improve patient outcomes. Through its efforts in vaccine development, the company seeks to address significant health challenges posed by viral infections.

C Ray Therapeutics develops healthcare advancements through nuclear medicine. It was founded in 2020.

Bio-Link is a drug development company founded in 2001 and headquartered in Shanghai, China. It specializes in providing bioprocessing solutions for the life science industry, including the development and manufacturing of key process equipment and consumables. Bio-Link's offerings include technologies for vaccines, antibody drugs, cell therapy, gene therapy, and various biologics. The company focuses on upstream cell culture, disposable dispensing reservoirs, and downstream processes such as chromatography and ultrafiltration. By delivering innovative products and services, Bio-Link aims to enhance the efficiency, safety, and competitiveness of the biopharmaceutical supply chain. Additionally, the company explores wearable technology solutions for elderly care, further diversifying its portfolio.

Wingtech Pharmaceuticals is an innovative pharmaceutical company that develop drugs for the treatment of chronic metabolic diseases.

Fat Fee is a health food supplier, mainly engaged in the healthy upgrading of oils and the development and application of fat replacement technology based on bio-oil refining technology, and has launched a series of edible oil products.

Hannuo Medical is a medical technology company that specializes in the development of high-end medical devices for critical extracorporeal life support.

Yantai Lannacheng Biotechnology is a biotech business that focuses on the building class I diagnosis and therapy integrated novel tumor nuclear medication research and development platform.and therapy integrated novel tumor nuclear medication research and development platform.

Maxvax Health is a biotechnology company focused on the development and commercialization of innovative vaccines. The company specializes in vaccine technology targeting viral diseases, including rotavirus, shingles, and herpes. By advancing these vaccines, Maxvax Health aims to enhance treatment options for healthcare professionals and improve patient outcomes. Through its efforts in vaccine development, the company seeks to address significant health challenges posed by viral infections.

Themis Medical provides comprehensive solutions for medical beauty diagnosis and treatment. It offers full medical and aesthetic department solutions, including ultrasound, radio frequency, optics, and skin detection.

3N Tech is a manufacturer specializing in contact lens care products designed to enhance eye health. The company utilizes advanced biotechnology, specifically biomedical electrophoresis deproteinization technology, to create a range of solutions for contact lens users. Their product offerings include methods for protein precipitation removal, sterilization, antibacterial treatment, and safe storage of contact lenses. By focusing on these innovative technologies, 3N Tech aims to provide effective safety protection for contact lens users, ensuring that they can maintain healthy eyes while using their products.

Sono Medical is a biomedical technology company that focuses on R&D, design, production and sales of edical equipment in the field of cardiovascular diseases.

Puncture Robotic is a developer of advanced venipuncture robots that facilitate automated blood collection and soft tissue interventions. The company's technology focuses on real-time image navigation to enhance precision in procedures such as percutaneous puncture for thoracoabdominal and pelvic tumors, as well as applications in medical aesthetics. Aiming to support medical institutions, Puncture Robotic provides intelligent and cost-effective robotic solutions that improve operational efficiency and patient care by enabling blood collection and other interventions without the need for human involvement.

Better Micro Medical is a medical device company that is characterized by intervention and non-implantation, and offers doctors with comprehensive solutions in the field of peripheral vascular and structural heart disease.

Svision is a healthcare start-up that develops and produces high-end ophthalmic imaging equipment.

Heproa is a micro-ecological skin care brand. It adheres to the new concept of micro-ecological scientific research and skin care. Ecological imbalance provides specialized skin care solutions.

Huaquejing Medical has developed a series of intelligent rehabilitation robots. They offer products that include upper-limb rehabilitation robots, finger rehabilitation robots, and cognitive rehabilitation robots. They provide services for the hospital and the family, from early rehabilitation intervention to sub-health prevention, from children's cognitive impairment to elderly limb disability.

Biosun Pharma is a biopharmaceutical company dedicated to developing drugs for cancer, autoimmune diseases, and inflammatory disorders. It focuses on molecular targeting and antibody drug development.

Rosenbot provides medical robot technology and uses technological innovation to promote the reform of medical models. It is committed to creating a new generation of orthopedic surgery robot systems with intelligent fracture reduction functions, it is the first in the world to realize advanced technologies such as intraoperative real-time 3D navigation, assisted fracture reduction operation, automatic operation planning, etc. The intelligent surgical operation of the whole operation process meets the urgent needs of clinical treatment.

Hualing Technology offers pharmaceutical retail operation and management solutions. Their digital smart empowerment platform offers single store, chain store management, chain management, member management, quality management, logistics management, inventory management, smart marketing, category optimization, business intelligence bi, and interface platform.

MicroPort (Shanghai) is a prominent developer, manufacturer, and marketer of advanced medical devices in China, primarily focusing on minimally invasive products for treating vascular diseases. Established in May 1998, the company specializes in a range of cardiovascular and diabetes devices, with its flagship product being a second-generation cobalt-chromium alloy drug-eluting stent. Additionally, MicroPort produces various vascular stent-grafts designed for addressing vascular conditions, as well as innovative stents for applications in the brain and other surgical contexts. The company's products have been utilized in over 1,100 hospitals across China and are exported to more than 20 countries in regions such as Asia Pacific (excluding China), South America, and Europe. MicroPort is committed to enhancing healthcare outcomes through its cutting-edge medical technologies.

Shenzhen TargetRx, Inc. is a high-tech pharmaceutical research and development company based in Shenzhen, China, founded in 2014. The company specializes in the research and development of third-generation small molecule targeted anti-tumor drugs aimed at addressing the challenges of drug resistance in cancer treatment. Led by Dr. Yihan Wang, an internationally recognized medical expert with extensive experience in the field, TargetRx focuses on designing, screening, evaluating, and optimizing novel pharmaceuticals for cancer patients. The company has developed a series of innovative anti-cancer solutions that possess independent intellectual property rights, with the goal of transforming cancer from a leading cause of death into a manageable chronic condition. TargetRx's commitment to advancing medical research in oncology is underscored by its dedication to improving treatment efficacy for patients facing the complexities of cancer.

Kai Medtech is a company that specializes in the development and supply of medical devices aimed at treating cerebrovascular diseases. It operates as a marketing and sales entity within the vascular intervention medical device sector, emphasizing the use of nerve intervention techniques. Committed to innovation, Kai Medtech integrates research and development with production and marketing to create comprehensive solutions that enhance patient care in the treatment of cerebrovascular and neurological conditions. The organization aims to establish itself as a leader in the vascular device industry by focusing on advanced neurointerventional technology.

Lingxi AR is a provider of augmented reality (AR) optical display technology, specializing in lightweight glasses with a large field of view. The company develops optical modules that utilize advanced nano-scale coupling gratings and optical waveguide technology, enabling AR 3D imaging with an impressive viewing angle of up to 36 degrees. Lingxi AR focuses on delivering cost-effective, transparent AR lenses that produce full-color imagery, catering to various sectors including education, healthcare, security, industrial maintenance, and fire protection. By offering robust display solutions, Lingxi AR aims to support partners in the AR industry with high-quality optical technologies that facilitate mass production and enhance user experiences.

Regend Therapeutics is a leading company in the field of human organ regenerative medicine, specializing in the development of stem cell therapy products. Its flagship product, REGEND001, is the world's first autologous stem cell preparation for treating respiratory diseases and has received approval from the State Food and Drug Administration. Regend Therapeutics is notable for being the first organization in China to be registered for conducting clinical research on stem cells, with its operations overseen by the National Health and Health Commission. The company is recognized as a key player in research and development by the Ministry of Science and Technology. Regend has achieved ISO9001:2008 quality management system certification, and its stem cell preparation complies with various national and international standards, including China Metrology Accreditation and the China Conformity Assessment Committee. All clinical programs are conducted in accordance with regulatory guidelines and are registered with the National Trial Global Database of the National Institutes of Health. The company's research focuses on solutions for interstitial lung disease, assisted reproduction, stem cell storage, and chronic obstructive pulmonary disease.

Accro Bioscience is a biopharmaceutical company that specializes in the development of innovative small molecule drugs aimed at treating inflammatory and autoimmune diseases, as well as cancer. The company conducts research on the molecular mechanisms underlying regulated cell death processes, including necroptosis, pyroptosis, and ferroptosis. By understanding these mechanisms, Accro Bioscience aims to enhance current therapeutic approaches and address specific pathologies associated with various human diseases.

Leyue Health, operated by Leyo Information Technology (Shanghai) Co., Ltd., is an innovative platform that integrates internet technology with medical health services. The company specializes in developing a commercial insurance direct payment platform that facilitates real-time online settlement of claims, significantly reducing the traditional 30-day claims processing time. By streamlining the reimbursement process, Leyue Health addresses common challenges faced by medical institutions and insurance providers, enhancing the user experience for insurance beneficiaries. In addition to its core settlement services, the company offers a mobile application that enables users to make appointments, manage test results, and process payments seamlessly. Leyue Health's approach fosters a more efficient and user-friendly connection between medical institutions and insurance providers, marking a significant advancement in the integration of healthcare and insurance technology.

BooHee is a mobile healthcare application focused on health and nutrition management. The platform offers personalized weight loss programs, effective tools for weight management, and features such as food calorie inquiries, diet analysis, and customized recipes. Additionally, BooHee provides slimming courses and a community forum to support users in achieving their health goals. By integrating various functionalities, the application aims to facilitate a straightforward approach to maintaining fitness and promoting overall well-being.

Comma Bio is a comprehensive solution provider for sample pretreatment. Based on two types of snap-neck material technologies of adsorption and separation materials and filter materials, the company has created three major technology platforms for porous plastics, separation materials and precision injection molding. Customers in the fields of, precision medicine, analysis and testing provide comprehensive solutions for sample pre-processing.

Mint Health is a pharmaceutical product distributor and wholesaler. MINT Health's primary business is the representation and distribution of various pharmaceutical brands in the Maltese market. MINT Health promotes wellness and self-care as natural parts of daily life. MINT Health's distribution network includes pharmacies, clinics, private hospitals, health shops, supermarkets, and central government procurement units.

Weijia Pediatrics is a chain of pediatric clinics that provide medical resources and child health management services.

Leads Biolabs is a biotechnology company based in China that focuses on developing innovative antibody-based therapeutics for oncology and immunological diseases. Founded in 2014, the company is dedicated to addressing global unmet medical needs by creating biopharmaceutical products that enhance treatment outcomes for patients. Leads Biolabs has established a strong research and development pipeline, featuring over ten projects centered on monoclonal and bispecific antibodies aimed at cancer immunotherapy. Through its commitment to advancing tumor immunotherapy, the company strives to improve the medical treatment and overall conditions of patients facing cancer.

OrbusNeich Medical is a global leader in vascular intervention solutions. It offers an extensive range of products that set industry standards.

JH Cispoly specializes in the development of diagnostic technology and equipment specifically aimed at the early detection of gynecological tumors. The company focuses on innovative solutions for identifying ovarian, cervical, and endometrial cancers, among others. By enhancing the capabilities for early diagnosis, JH Cispoly plays a crucial role in improving patient outcomes through timely intervention in gynecological health.

BooHee is a mobile healthcare application focused on health and nutrition management. The platform offers personalized weight loss programs, effective tools for weight management, and features such as food calorie inquiries, diet analysis, and customized recipes. Additionally, BooHee provides slimming courses and a community forum to support users in achieving their health goals. By integrating various functionalities, the application aims to facilitate a straightforward approach to maintaining fitness and promoting overall well-being.

YuanHua Zhineng specializes in sophisticated medical and intelligent service robots. The company provides a robot system for orthopedic surgery that can help surgeons with a variety of procedures, including spine, knee/hip replacement, trauma, and knee/hip replacement.

BioHeng is a clinical biopharmaceutical and biotechnology Company focuses on novel immunotherapy and next-generation gene therapy development for treating cancers and various diseases. Founded in 2017, Bioheng has established a high standard GMP grade clinical translational center, and is leading in the field of cell engineering, proliferation and clinical applications. Particularly, Bioheng owns several cutting-edge patents plus extensive industry experience, and has built a complete, closed and automated production system in compliance with regulatory guidelines. In 2018, Bioheng has successfully raised tens of millions of RMB seeding fund from Simcere Pharmaceutical Group, aiming to accelerate the development of immunotherapy via integrating resources from both parties. Bioheng is dedicated to develop safer, effective and less expensive cell therapy drugs to benefit more patients.

TytoCare develops handheld devices and software that enable users to perform self-examinations, facilitating remote diagnosis by healthcare professionals. The company's tools allow examination of various body areas and diagnose common conditions. TytoCare offers solutions for consumers (TytoHome), professionals (TytoPro), and remote clinics (TytoClinic). Incorporated in 2011, the company is headquartered in Netanya, Israel with an additional office in New York.

Cryofocus Biotech is a Shanghai-based cryoablation device manufacturer, focusing on the application of cryogenic technology in the field of cardiovascular interventional therapy.

SinoVision is a medical device manufacturing company based in China, established in 2012. It specializes in the development of computed tomography (CT) scanners, offering a range of products including 16-Slice, 32-Slice, and 64-Slice CT scanners. The company also provides advanced technologies such as the sROBOT robot CT navigation system and sAI intelligent imaging solutions. SinoVision holds intellectual property for CT detectors and designs X-ray tubes and high-voltage power supplies specifically for CT scanners. Additionally, it operates a cloud diagnosis platform that integrates CT image post-processing workstations with an online consultation platform, facilitating comprehensive imaging diagnoses for healthcare professionals and institutions.

Ark Biosciences Inc. is a biopharmaceutical company based in Shanghai, China, specializing in the discovery and development of therapeutics aimed at addressing unmet medical needs, particularly in the areas of respiratory viral infections and viral hepatitis. Founded in 2013, the company focuses on developing innovative treatments, including AK0701 for chronic obstructive pulmonary disease, AK0529 for respiratory syncytial virus, AK0612 for influenza, and AK0705 and AK0706 for hepatitis B. Ark Biosciences is committed to advancing antiviral drug research and development to serve both global and Chinese markets.

Laekna Therapeutics is a clinical‑stage biotechnology company that develops novel therapies for oncology and liver disease. The company has built a comprehensive research and development platform that moves molecules from discovery to registration‑ready trials. It has initiated six clinical studies, including three multi‑regional trials targeting standard‑of‑care resistant cancers. Its lead product candidates are LAE002, an ATP‑competitive AKT inhibitor for ovarian cancer, and LAE001, a therapeutic agent for liver disease. Laekna also maintains a broader pipeline of 14 additional candidates.

Shanghai Horizon Medical Technology focuses on medical solutions its business covers the R&D, manufacturing, marketing, and technical support of products at every step of the ART treatment process, including egg and sperm collection, fertilization, embryo culture, cryopreservation, and embryo transfer. It was founded in 2018 and headquartered in Shanghai, China.

Shenzhen TargetRx, Inc. is a high-tech pharmaceutical research and development company based in Shenzhen, China, founded in 2014. The company specializes in the research and development of third-generation small molecule targeted anti-tumor drugs aimed at addressing the challenges of drug resistance in cancer treatment. Led by Dr. Yihan Wang, an internationally recognized medical expert with extensive experience in the field, TargetRx focuses on designing, screening, evaluating, and optimizing novel pharmaceuticals for cancer patients. The company has developed a series of innovative anti-cancer solutions that possess independent intellectual property rights, with the goal of transforming cancer from a leading cause of death into a manageable chronic condition. TargetRx's commitment to advancing medical research in oncology is underscored by its dedication to improving treatment efficacy for patients facing the complexities of cancer.

QureBio focuses on the research and development of innovative macromolecular biopharmaceuticals. Its goal is to develop new therapeutic drugs for the treatment of refractory cancer, autoimmune diseases, and metabolic diseases in China and the world to benefit patients. QureBio has multiple technology platforms for antibody drug development including phage display technology platforms and hybridoma antibodies technology platform and monoclonal antibody platform. The company was founded in 2017 and is based in Pudong District, Shanghai.

GenFleet Therapeutics, established in 2017 and headquartered in Shanghai, China, is a biotechnology company focused on cancer research and development. It specializes in creating therapeutic molecules, including signal transduction regulators, tumor microenvironment modulators, and transcription factors, to target various cancer systems. The company aims to develop innovative molecular-level pharmaceuticals and antibody drugs that can effectively stimulate the body's immune response against tumors. GenFleet serves both domestic and international clients.

Lachesis is a high-tech company based in Shenzhen, China, specializing in clinical applications that integrate information and communications technology with internet technology. The company develops intelligent products and services aimed at enhancing the efficiency of healthcare delivery for doctors, nurses, patients, and hospitals. Its offerings include a bedside nursing solution, an interactive smart ward solution, and an IoT platform, all designed to improve management efficiency and accuracy in medical assessments. By providing mobile medical intelligent hardware and application software, Lachesis aims to advance mobile nursing and intelligent medical practices within healthcare institutions.

Remegen is a Chinese biopharmaceutical company focused on developing novel biologics, primarily monoclonal antibodies (mAbs) and antibody-drug conjugates (ADCs), to address unmet medical needs in life-threatening conditions. Headquartered in Yantai with labs/offices in Beijing and California, Remegen's portfolio includes Telitacicept for systemic lupus erythematosus and Disitamab Vedotin for various cancers.

Zhimeng Biopharma, established in 2017 and headquartered in Shanghai, China, specializes in developing innovative medicines for chronic hepatitis B (CHB) and related liver diseases. Its portfolio includes HBV capsid inhibitor (CB-001), HBsAg inhibitor, TLR8 agonist, OX-40 agonist, and KCNQ2/3 K+ channel opener for epilepsy. Additionally, Zhimeng is actively exploring novel small molecule drugs to address neurological conditions like epilepsy, pains, and strokes.

Founded in 2012, Akeso Biopharma operates as a contract research organization (CRO) specializing in antibody and protein drug discovery and development. It offers integrated platforms for services such as protein expression and purification, gene-to-structure analysis, antibody generation, assay development, humanization, and affinity maturation. Serving both domestic and international biotech and pharmaceutical clients, Akeso Biopharma is headquartered in Zhongshan, China.

Hrain Biotechnology is a developer of tumor immunotherapy technologies focused on delivering precise treatments for cancer patients. The company employs Chimeric Antigen Receptor T-cell (CAR-T) technology to enhance the effectiveness of cancer therapies. By establishing clinical trial platforms in various locations, including Beijing, Jiangsu, Chongqing, and Henan, Hrain Biotechnology facilitates the development and implementation of innovative medical treatments in clinical settings. Through its research and technology, the company aims to improve patient outcomes by enabling hospitals and clinics to offer advanced therapeutic solutions tailored to individual needs.

Fanmi Technology Limited, based in Chengdu, China, specializes in the research and development of intelligent maternal and baby health products. With six years of experience in creating professional medical products, the company is dedicated to delivering safe and reliable solutions for infant care. Its product range includes innovative items such as a chip for excreta identification and analysis, an intelligent thermometer for forehead temperature detection, and a toilet test solution. Fanmi Technology aims to leverage advanced technology to enhance the well-being of mothers and their children.

Beijing Lidakang Technology Co., Ltd., established in 1998, specializes in the manufacturing and distribution of surgical implants. Its product portfolio includes artificial joint systems for hips, knees, and bone tumors, crafted from materials like microporous titanium alloy. These high-quality implants are designed to meet the needs of healthcare professionals and improve patient outcomes.

Hepanova is a clinical-stage pharmaceutical company focused on discovering, developing, and commercializing therapeutics for chronic liver diseases. Founded in 2014 and based in Gaithersburg, Maryland, the company pursues treatments for conditions with high unmet medical needs, including non-alcoholic fatty liver disease, non-alcoholic steatohepatitis, hepatic fibrosis, hepatitis B, and hepatocellular carcinoma. Hepanova operates globally, advancing multiple research programs through early and mid-stage development with the aim of offering patients innovative therapies to address liver disease.

TytoCare develops handheld devices and software that enable users to perform self-examinations, facilitating remote diagnosis by healthcare professionals. The company's tools allow examination of various body areas and diagnose common conditions. TytoCare offers solutions for consumers (TytoHome), professionals (TytoPro), and remote clinics (TytoClinic). Incorporated in 2011, the company is headquartered in Netanya, Israel with an additional office in New York.

Founded in 2012, Akeso Biopharma operates as a contract research organization (CRO) specializing in antibody and protein drug discovery and development. It offers integrated platforms for services such as protein expression and purification, gene-to-structure analysis, antibody generation, assay development, humanization, and affinity maturation. Serving both domestic and international biotech and pharmaceutical clients, Akeso Biopharma is headquartered in Zhongshan, China.

Zhiyi Pharmaceutics Inc., established in 2013 and based in Guangzhou, China, specializes in the research and development of next-generation probiotics (NGPs) and live biotherapeutics (LBPs). The company's product pipeline includes SK08, TP2, ZY19, and SK09, all targeted at treating gastrointestinal disorders. Zhiyi Pharmaceutics focuses on innovative drug discovery, with a particular emphasis on the development of its proprietary strain SK08, which is poised to enter clinical trials. The company aims to expand its research into the relationship between human microbiome and disease, including microbial culture groups and pathobionts research, as well as the identification and separation of new functional strains.

Shenzhen TargetRx, Inc. is a high-tech pharmaceutical research and development company based in Shenzhen, China, founded in 2014. The company specializes in the research and development of third-generation small molecule targeted anti-tumor drugs aimed at addressing the challenges of drug resistance in cancer treatment. Led by Dr. Yihan Wang, an internationally recognized medical expert with extensive experience in the field, TargetRx focuses on designing, screening, evaluating, and optimizing novel pharmaceuticals for cancer patients. The company has developed a series of innovative anti-cancer solutions that possess independent intellectual property rights, with the goal of transforming cancer from a leading cause of death into a manageable chronic condition. TargetRx's commitment to advancing medical research in oncology is underscored by its dedication to improving treatment efficacy for patients facing the complexities of cancer.

HaploX Biotechnology Co., LTD. is a Shenzhen-based company established in 2014 that focuses on developing genomic solutions for personalized medicine, particularly in cancer patient management. The company specializes in integrating advanced technologies such as liquid biopsy, gene sequencing, artificial intelligence, and big data to enhance cancer diagnostics. HaploX's innovative genomics technology enables the extraction and amplification of ultra-low concentrations of DNA from liquid samples, facilitating the precision capture of circulating tumor DNA. By leveraging these advanced methodologies, the company aims to improve the detection and management of ultra-micro tumors, ultimately contributing to more effective patient care in oncology.

Meierbei.com provides pre-operative advice, intra-operative treatment, and post-operative care to their customers through medical aesthetic consultants. Their customers inquiries are addressed through phone, email, and online applications.

Imsight Medical Technology Co. Ltd. is a company specializing in artificial intelligence-assisted medical imaging analysis software and tools for the healthcare industry. Founded in 2016 and headquartered in Shenzhen, China, with additional offices in Hong Kong, Chengdu, and Beijing, Imsight provides advanced solutions that enhance the accuracy of clinical diagnosis and treatment. The company's offerings include microscopy image analysis, lung cancer screening, radiotherapy contouring, and cervical cancer screening. By leveraging deep learning and intelligent data analysis, Imsight aims to deliver fast and precise evaluations of vast quantities of medical images. Their technology supports healthcare professionals by offering insightful diagnosis results and tailored treatment recommendations, ultimately improving the efficiency and effectiveness of medical services in hospitals and diagnostic centers.

Zelgen is a biopharmaceutical company based in Suzhou, China, dedicated to the innovation, research, development, manufacture, and sales of new medications. The company aims to establish itself as a leader in the Chinese biopharmaceutical industry, focusing on treatments for cancer, hematologic diseases, and other significant health challenges. Zelgen's business strategy emphasizes addressing unmet medical needs within the domestic market by developing high-quality, safe, effective, and affordable medications. The company's research and development efforts encompass new chemical and biological drugs across various therapeutic areas, including tumors and liver-related diseases.

Founded in 2012, Akeso Biopharma operates as a contract research organization (CRO) specializing in antibody and protein drug discovery and development. It offers integrated platforms for services such as protein expression and purification, gene-to-structure analysis, antibody generation, assay development, humanization, and affinity maturation. Serving both domestic and international biotech and pharmaceutical clients, Akeso Biopharma is headquartered in Zhongshan, China.

Frontier Biotechnologies Inc. is a commercial-stage biopharmaceutical company headquartered in Nanjing, China, specializing in the discovery, development, and manufacturing of innovative medicines aimed at improving patient health. Founded in 2013, the company addresses unmet medical needs primarily in anti-HIV treatment and pain management. Its notable products include Aikening, a long-acting HIV fusion inhibitor, and AB001, a transdermal patch designed for musculoskeletal joint pain relief. Additionally, the company is developing a combination regimen of Albuvirtide and 3BNC117, a monoclonal antibody targeting HIV-1 viruses. Frontier Biotech's commitment to excellence spans the entire development cycle, from drug discovery to global clinical trials, with multiple candidates currently in Phase I and Phase II trials in both China and the United States. The company's focus on long-acting therapies and differentiated products positions it as a competitive player in the biopharmaceutical industry.

SHENZHEN C.K.J STOMATOLOGICAL HOSPITAL offers services for oral diagnostics and treatment. Concentrating on oral disciplines, there are oral implantology, orthodontics, prosthodontics, endodontics, periodontics, children's stomatology, oral prophylaxis, and oral and maxillofacial surgery.

BOZWIN is engaged in the research and development, production, and sales of medical imaging products. They provide general imaging services in different scenarios, including routine outpatient clinics, fever clinics, emergency centers, physical examination centers, radiotherapy centers, and inpatient buildings.

Mai Yi develops products and platforms such as communication clouds, rendering clouds, IoT clouds, hybrid clouds, and more. They provide large-scale services to customers in computing, education, medical care, finance, transportation, and other industries.

Medcaptain develops and provides medical instruments and related services across infusion management, in-vitro diagnostics, and rehabilitation care, with additional offerings in medication delivery, anesthesia and respiratory care. The company focuses on innovation in medical instruments and aims to supply local, innovative solutions to healthcare providers, supporting access to high-quality medical products and services. It also pursues corporate social responsibility by creating jobs and contributing to societal value.

Zelgen is a biopharmaceutical company based in Suzhou, China, dedicated to the innovation, research, development, manufacture, and sales of new medications. The company aims to establish itself as a leader in the Chinese biopharmaceutical industry, focusing on treatments for cancer, hematologic diseases, and other significant health challenges. Zelgen's business strategy emphasizes addressing unmet medical needs within the domestic market by developing high-quality, safe, effective, and affordable medications. The company's research and development efforts encompass new chemical and biological drugs across various therapeutic areas, including tumors and liver-related diseases.

Haici Technology is a developer of a SaaS-based mobile healthcare service platform aimed at enhancing hospital operations. The company focuses on improving the efficiency of hospital visits, reducing patient wait times, and expanding the range of services offered by healthcare institutions. Its platform integrates online and offline medical services, facilitating better connections between hospitals and patients. By optimizing the patient experience and streamlining administrative workflows, Haici Technology supports hospitals in delivering more effective and efficient healthcare services.

iTO Technology offers information management services for the medical industry. They provide products that include medito cardio, medito MDG, medito, medito AED, and medito ED. An online inquiry form is available on the company's website.

Founded in 2012, Akeso Biopharma operates as a contract research organization (CRO) specializing in antibody and protein drug discovery and development. It offers integrated platforms for services such as protein expression and purification, gene-to-structure analysis, antibody generation, assay development, humanization, and affinity maturation. Serving both domestic and international biotech and pharmaceutical clients, Akeso Biopharma is headquartered in Zhongshan, China.

JHOME is an import and export rights company and an Internet B2C sales platform for drugs and medical devices. Their production and sales of in vitro diagnostic reagents and instruments, medical imaging, and medical electronic equipment. They focus on product and technological innovation in the fields of medical care, family health, and public safety.

Coolplay is a mobile Internet company that focuses on smart fitness product research and development. It is a smart sports company that provides smart heart rate training solutions for professional fitness equipment manufacturers, gyms, and studios. Physical fitness and sports evaluation system solutions for primary and secondary schools, as well as medical institutions; online smart fitness applications, as well as smart fitness equipment and accessories for smart TV manufacturers Provide individual sports enthusiasts with entertainment and fitness platforms, as well as customized exercise guidance programs.

Virogin Biotech Ltd., founded in 2015 and based in Vancouver, Canada, specializes in the development of oncolytic virus therapeutics aimed at treating cancer. The company utilizes its innovative Synerlytic™ technical platform to enhance cancer treatment through novel immunotherapy approaches. Virogin's technology focuses on leveraging immunological principles to stimulate anticancer and antitumor immunity. By harnessing a robust and transient antiviral immune response, the company aims to improve systemic antitumor immunity via synergistic interactions with multiple therapeutic payloads. Virogin is dedicated to advancing its position as a leader in the field of immuno-oncology.

Genrui Biotech Inc., formerly known as Shenzhen Genius Electronics Co., Ltd, is a prominent Chinese company established in 2004 that specializes in the development, manufacturing, and marketing of in vitro diagnostic (IVD) equipment and reagents. The company offers a diverse product range that includes immunoassay, chemistry, hematology, urinalysis, and point-of-care diagnostics, alongside related reagents. Genrui has made significant strides in product innovation and has expanded its market presence, serving customers not only throughout China but also in over 100 countries globally. The company is committed to providing high-quality IVD medical products to healthcare practitioners.

Genrui Biotech Inc., formerly known as Shenzhen Genius Electronics Co., Ltd, is a prominent Chinese company established in 2004 that specializes in the development, manufacturing, and marketing of in vitro diagnostic (IVD) equipment and reagents. The company offers a diverse product range that includes immunoassay, chemistry, hematology, urinalysis, and point-of-care diagnostics, alongside related reagents. Genrui has made significant strides in product innovation and has expanded its market presence, serving customers not only throughout China but also in over 100 countries globally. The company is committed to providing high-quality IVD medical products to healthcare practitioners.

Hornetcorn is a company dedicated to the research and development of tumor-specific immune cells and gene technologies, primarily serving the biotechnology sector. It specializes in advanced cell therapy techniques, including CAR-T, D-CTL, D-CIK, and ECIK. Hornetcorn's activities encompass clinical research and applications, as well as technical services, aimed at providing innovative treatment solutions for clients and patients facing cancer-related challenges. Through its focused efforts in cell technology, the company plays a significant role in advancing therapeutic options within the field of biotechnology.

Suzhou Tianma Medical Group is a large-scale technology enterprise that integrates fine chemicals, bio-pharmaceuticals, and tourism real estate. The company has focused on industrialization and standardization to develop a robust operational model that fosters the interaction between capital and industrial activities. Suzhou Tianma Medical Group has transitioned from producing traditional pharmaceutical intermediates and ingredients to full pharmaceutical preparations, establishing itself as a key supplier of domestic crude drugs. The company's product offerings span several sectors, including fine chemicals, advanced pharmaceutical intermediates, pharmaceutical raw materials, and paper-making chemicals. Through strategic investments and technological innovation, the group actively seeks opportunities for industrial expansion and development.

Xierkang (希尔康血液) is a Chinese high-tech enterprise engaged in the research and development, production, and clinical research of blood purification equipment. The company has committed itself to the research and production of blood hemoperfusion apparatus. Its product portfolio includes six domains of resin adsorption column, resin carbon adsorption column, bilirubin adsorption column, low density cholesterol protein adsorption column, endotoxin adsorption column, and specific adsorption column. Xierkang is focused on the development of hemoditoxifier, and owns the proprietary intellectual property rights for its raw material synthesis, specialized equipment production, and tank body design.

AILV is a production and sales system for reproductive health products at Topco. They offer the circulation of reproductive health products, family planning and reproductive health care, information, and culture. They build an Internet community forum, cultivate sticky consumers, provide members with sexologists, sex psychologists, private topics, girlfriends, gender topic experts, entertainment stars, and an interactive dating platform.

BGI Tech Solutions Co., Ltd., founded in 2012 and headquartered in Shenzhen, China, is a leading provider of advanced life sciences technology and bioinformatics services. The company operates lab facilities in Hong Kong, Wuhan, and Sacramento, along with branch offices in various regions, including Europe, the Americas, and multiple cities in mainland China. BGI Tech's extensive service network spans over 100 countries and regions, collaborating with more than 10,000 organizations and 30,000 partners on a multitude of research projects, including significant international genome initiatives. The company specializes in a wide range of sequencing solutions, including genomics, transcriptomics, epigenomics, metagenomics, PDXomics, and single-cell sequencing, among others. Through its commitment to integrated omics platforms, BGI Tech aims to accelerate advancements in life sciences and address critical health, agricultural, energy, and environmental challenges, ultimately contributing to the betterment of society.

Rundo Medical is a contract research organization (CRO) that focuses on providing comprehensive clinical research outsourcing services to pharmaceutical and biotechnology companies. It specializes in a range of high-quality solutions, including clinical operations, medical data management, biostatistics, and medical project management. As a prominent player in the CRO industry, Rundo Medical is a key initiator and promoter of the China CRO Alliance. The company has distinguished itself by being the first in its sector to achieve ISO 9001:2008 quality management system certification, combined with CRO industry standard certification. Through its professional services, Rundo Medical supports various clients in advancing their medical research and operational objectives.

Hakim Unique Internet Co., Ltd, established in 2002 and publicly listed in 2012, operates primarily as a service provider focusing on smart city, finance, smart medical care, and commerce sectors. The company leverages its extensive experience in engineering and financing to offer comprehensive services in smart city planning, integration, and operation, supported by its strong research and development capabilities. Hakim Unique has developed a unique operational model that integrates financial instruments into its smart city initiatives, enhancing its competitive edge. In the realm of smart medical care, the company has created the Great Health Companion platform, facilitating access to medical services and fostering collaborations with top hospitals to establish cross-border medical care channels between China and the United States. Future plans include providing intermediary medical services and offering advanced medical products on its platform, utilizing artificial intelligence to enhance the overall healthcare service experience. Guided by its founders, Wang Qicheng and Wu Yan, Hakim Unique aims to establish itself as a leading function-providing platform through the integration of intelligent technologies.

ZKML provides digital medical technology and medical information software. They also provide research and development, digital medical equipment with completely independent intellectual property rights, and a comprehensive medical information software system.

MicroPoint Bioscience, Inc. is a Chinese company focused on the research and development of biochips. It specializes in the manufacturing of point-of-care testing (POCT) equipment and biological diagnostic test reagent cards, primarily for medical applications. The company's Lab On a Chip product series leverages micro-electronic mechanical systems (MEMS) to offer advanced microfluidic bio-diagnostic testing solutions. These innovations facilitate early diagnosis and monitoring of critical health issues, including vascular diseases and tumors. MicroPoint Bioscience customizes its products and services to meet the needs of various sectors, including human health, environmental protection, food safety, and scientific research, thereby contributing to improved healthcare outcomes and operational efficiency in medical settings.

Weifang Pharmaceutical Factory Co., Ltd. (潍坊制药厂) is a Chinese joint-stock pharmaceutical enterprise that integrates production and operation, research and development, as well as domestic and foreign trade. The company currently has assets of 0.154 billion Yuan. It has over 50 steady dealers and agencies who sell products directly to nearly 3,000 hospitals in big- and medium-sized cities all over the country. Its generic drug products are sold to markets of small- and medium-sized cities and villages, while bulk drug products are mainly sold to drug markets in Europe and the United States. Weifang Pharmaceutical Factory was founded in 1966.

Chenguang Biotech Group Co., Ltd. specializes in the processing of agricultural products and natural extracts, producing over 80 types of products across four main categories: natural pigments, natural spice extracts and essential oils, natural nutrients and drug-use extracts, and grease and protein. The company is recognized for its leadership in the production and sales of natural pigments in China, with capsanthin being the top product globally and chili extract accounting for over 85% of domestic volume. Chenguang also manufactures a variety of spice extracts and essential oils, including paprika oleoresin, ginger oil, and turmeric oil, among others. As a national high-tech enterprise, it has established various research and development platforms and holds numerous patents, reflecting its commitment to innovation and quality in the agricultural industrialization sector.

Shenzhen Glory Medical Co., Ltd. specializes in integrated solutions for hospital construction and management in China. Founded in 1998 and headquartered in Shenzhen, the company offers a comprehensive range of services including hospital system analysis, planning, and medical engineering. Additionally, Glory Medical is involved in the design, decoration, and construction of hospital buildings, as well as the research, development, and production of medical equipment and facilities. The company provides one-stop services encompassing preliminary consulting, project financing, operation, maintenance, and logistics management. Glory Medical also markets medical equipment and consumables while maintaining a robust distribution and service network through various subsidiaries and branch offices across China.

Shanghai Celgen Biopharma Co., Ltd. is a biopharmaceutical company specializing in the research, development, production, and sales of biological medicinal products, particularly recombinant proteins and monoclonal antibodies aimed at treating immune diseases and cancer. The company has established a robust professional platform that includes a phage antibody screening library and a CHO cell clone development platform, both recognized by regulatory bodies such as the FDA and EMEA. Additionally, Celgen Biopharma has developed advanced capabilities for serum-free and antibiotic-free CHO cell culture, along with sophisticated purification and analytical platforms. Their focus on innovative technology and quality design underpins their commitment to improving patient health outcomes through effective biologic drugs.

Suzhou Tianma Medical Group is a large-scale technology enterprise that integrates fine chemicals, bio-pharmaceuticals, and tourism real estate. The company has focused on industrialization and standardization to develop a robust operational model that fosters the interaction between capital and industrial activities. Suzhou Tianma Medical Group has transitioned from producing traditional pharmaceutical intermediates and ingredients to full pharmaceutical preparations, establishing itself as a key supplier of domestic crude drugs. The company's product offerings span several sectors, including fine chemicals, advanced pharmaceutical intermediates, pharmaceutical raw materials, and paper-making chemicals. Through strategic investments and technological innovation, the group actively seeks opportunities for industrial expansion and development.

Xi'an Haotian Biological Engineering technology Co., Ltd (西安皓天) is a Chinese raw material supplier to the global health industry. Xi'an Haotian is specialized in manufacturing quality and reliable raw materials for many industries including functional food, nutritional supplement, cosmetic, pharmaceutical, and feed. It is one of the main raw material exporters in the health industry in China. The researchers in the firm accounts for 31.8% of total number including five doctors and fifteen masters, who are specialized in the fields of extraction and separation, synthetizing, fermenting, pharmacy, dietetics, and more. Xi'an Haotian was established in February 2003.

MicroPort (Shanghai) is a prominent developer, manufacturer, and marketer of advanced medical devices in China, primarily focusing on minimally invasive products for treating vascular diseases. Established in May 1998, the company specializes in a range of cardiovascular and diabetes devices, with its flagship product being a second-generation cobalt-chromium alloy drug-eluting stent. Additionally, MicroPort produces various vascular stent-grafts designed for addressing vascular conditions, as well as innovative stents for applications in the brain and other surgical contexts. The company's products have been utilized in over 1,100 hospitals across China and are exported to more than 20 countries in regions such as Asia Pacific (excluding China), South America, and Europe. MicroPort is committed to enhancing healthcare outcomes through its cutting-edge medical technologies.

MicroPort (Shanghai) is a prominent developer, manufacturer, and marketer of advanced medical devices in China, primarily focusing on minimally invasive products for treating vascular diseases. Established in May 1998, the company specializes in a range of cardiovascular and diabetes devices, with its flagship product being a second-generation cobalt-chromium alloy drug-eluting stent. Additionally, MicroPort produces various vascular stent-grafts designed for addressing vascular conditions, as well as innovative stents for applications in the brain and other surgical contexts. The company's products have been utilized in over 1,100 hospitals across China and are exported to more than 20 countries in regions such as Asia Pacific (excluding China), South America, and Europe. MicroPort is committed to enhancing healthcare outcomes through its cutting-edge medical technologies.

Shenzhen Anke Hi-Tech Co., Ltd. is a high-tech enterprise based in Shenzhen, China, specializing in the research, development, manufacturing, and servicing of advanced medical equipment. The company produces a wide range of products, including MRI, CT, X-ray, and ultrasound systems, as well as devices for orthopedics and neurosurgery. Anke has established itself as a pioneer in the Chinese market, being the first to manufacture various medical technologies such as MRI and color ultrasonography. Its operations also encompass medical informatics and therapeutics, addressing the needs of both domestic and international customers. Founded in 1986 and originally known as Analogic Scientific, Inc., the company rebranded in 2001 to reflect its focus on high-tech medical solutions.